Crewe Advisors LLC Agilent Technologies, Inc. Transaction History

Crewe Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$129.63 - $154.64 $13,092 - $15,618	101 Added 114.77%	189 $24,000
Q1 2024 May 13, 2024	BUY	$128.12 - $149.31 $11,274 - $13,139	88 New	88 $12,000
Q4 2022 Feb 07, 2023	SELL	$125.64 - $157.68 $18,720 - $23,494	-149 Reduced 73.04%	55 $8,000
Q3 2022 Nov 14, 2022	BUY	$115.11 - $142.29 $5,064 - $6,260	44 Added 27.5%	204 $25,000
Q2 2022 Aug 02, 2022	BUY	$112.71 - $135.93 $18,033 - $21,748	160 New	160 $19,000
Q4 2020 Jan 27, 2021	SELL	$100.01 - $119.3 $1,600 - $1,908	-16 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$88.11 - $103.42 $1,409 - $1,654	16 New	16 $2,000
Q3 2019 Nov 06, 2019	SELL	$65.59 - $78.07 $524 - $624	-8 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$63.27 - $82.0 $506 - $656	8 New	8 $1,000

1,148

252M

729K

970K

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $39.8B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.